Jennifer Kimball has sold WEX and made no open-market buys since Jun 2022

Jennifer Kimball is a corporate insider and seasoned finance executive who serves as Chief Accounting Officer at WEX Inc. (NYSE: WEX).( She joined WEX in April 2019 and was promoted to Chief Accounting Officer in August 2020, bringing more than two decades of financial leadership experience across public and private companies.( In her current role, she oversees WEX’s financial reporting, accounting, and internal controls, with deep expertise in complex accounting, SEC reporting, derivatives and hedging, and equity-based compensation.( She has also been identified in SEC Form 4 filings as a reporting insider due to her equity transactions in WEX stock under Rule 10b5‑1 trading plans.(

Before WEX, Kimball served as Chief Accounting Officer at Syneos Health, a global biopharmaceutical solutions company, and held key finance and public accounting roles at inVentiv Health, The Timberland Company, Thermo Fisher Scientific Inc., and PricewaterhouseCoopers, gaining substantial M&A, integration, and audit experience.( She briefly served as Interim Chief Financial Officer of WEX in early 2022 before returning full time to the Chief Accounting Officer position following the appointment of a new CFO.( Kimball holds a bachelor’s degree in Accounting and Sociology from Boston College and is a certified public accountant (CPA), and is based in Portland, Maine.(

Written by Perplexity from public sources.